Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounding for Degenerative Myelopathy in the German Shepherd

Author(s):  Timmons Steven P

Issue:  Jul/Aug 1997 - Compounding for Animals
View All Articles in Issue

Page(s):  241

Compounding for Degenerative Myelopathy in the German Shepherd Page 1

Download in electronic PDF format for $75

Abstract:  Degenerative myelopathy is a degenerative disease that causes demyelination of the spinal cord, especially in the thoracolumbar region of affected dogs. It appears with increased frequency in the German Shepherd. Here the author, a veterinarian, discusses diagnosis and treatment involving vitamins (vitamins E, C and B); aminocaproic acid and N-acetylcysteine.

Related Keywords: dogs, animals, veterinary, n-acetylcysteine, amicar, aminocaproic

Related Categories: VETERINARY

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Compounding for Degenerative Myelopathy in the German Shepherd
Timmons Steven P
Jul/Aug 1997
Pg. 241

Calculations
Prince Shelly J
Sep/Oct 2002
Pg. 387

Navigating New Territories in Compounding for Veterinary Medicine
Davidson Gigi S
Sep/Oct 2002
Pg. 324-327

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2
Davidson Gigi S
May/Jun 2001
Pg. 214-215

Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Zhang Yan-ping
, Trissel Lawrence A
Mar/Apr 1997
Pg. 132-134

N-acetylcysteine Used to Decrease the Incidence of Contrast-Induced Nephropathy Following Radiographic Procedures: A Literature Review
McElhiney Linda F
Mar/Apr 2005
Pg. 99-103

Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Davidson Gigi S
Sep/Oct 2002
Pg. 332-336

Providing Positive Outcomes through Compounding for Animal Cancer Patients
Davidson Gigi S
Jul/Aug 2000
Pg. 264-272

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R
, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012
Pg. 34-41

The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E
, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Sep/Oct 2019
Pg. 428-433

When is Compounding for Animals Legal?
Siegner A Wes Jr
May/Jun 1999
Pg. 188-191

The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
Mar/Apr 2001
Pg. 86-88

Drugs Banned for Use in Food Animals: An Explanation
Davidson Gigi S
Mar/Apr 2001
Pg. 101-103

Compounding for Cancer in Companion Animals
Mixon William
, Northrup Nicole, Vail Jane
Jan/Feb 2009
Pg. 42-49

When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
Jan/Feb 2017
Pg. 19-21

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Canine Public Servants: Caring for Drug Detection Dogs
Davidson Gigi S
Sep/Oct 2008
Pg. 384-390

Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1
Davidson Gigi S
Mar/Apr 2001
Pg. 95-96

Return to Top